Skip to contentI
InspireMD, Inc.
I
NSPRInspireMD, Inc. Q2 2023 · 10-Q
Revenue$1.65M$1.65M+7.7% vs Q2 2022 Net Income-$5.08M-$5.08MN/M vs Q2 2022 EPS Diluted-$0.24-$0.24N/M vs Q2 2022 Gross Profit$491,000+13.9% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
InspireMD, Inc. · CIK 1433607 · Engraved from SEC EDGAR
Operating Cash Flowderived-$3,325,000N/M Free Cash Flowderived-$3,370,000N/M Margins · derivedGross margin29.8%+1.6 pt vs Q2 2022
Operating margin-322.3%−16.6 pt vs Q2 2022
Net margin-307.9%−5.1 pt vs Q2 2022
ended Jun 30, 2023 · filed Aug 7, 2023 · 38 d after period end